AORT

Artivion, Inc.

$21.53

Current Price

All

AI analysis

Read what the AI thinks of Artivion, Inc. in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$0.07

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.06

Oct 29

Posts

No posts about AORT yet.

About Artivion, Inc.

Artivion makes medical devices and preserved human tissue used in heart and aortic surgery. Its products include stent grafts that repair a torn or bulging aorta (the body's main artery), mechanical heart valves, and a surgical glue called BioGlue. Hospitals buy these products, and that is how the company earns its revenue.